Wikisage, the free encyclopedia of the second generation, is digital heritage

Gabapentine: Difference between revisions

From Wikisage
Jump to navigation Jump to search
({{refs}})
No edit summary
(One intermediate revision by the same user not shown)
Line 1: Line 1:
gabapentin -gabapentinoid (see also pregabalin)- is an anticonvulsant agent
gabapentin -gabapentinoid (see also pregabalin)- is an anticonvulsant agent
and off label for the treatment of alcohol dependence<ref>http://ns.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf Examination of the Evidence for Off-Label Use of Gabapentin</ref>
and off label for the treatment of alcohol dependence<ref>[http://ns.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf Examination of the Evidence for Off-Label Use of Gabapentin]</ref>


Hallucinations as abuse substance has been reported, and fatalities has been reported in concomitant use with opioids
Hallucinations as abuse substance has been reported, and fatalities has been reported in concomitant use with opioids
==ATC==
==ATC==
 
<gallery>File:Gabapentin_3D.png</gallery>
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
|colspan=2| <center>
|colspan=2| <center>
Line 12: Line 12:
|}
|}


[[Category:Anticonvulsants]]
==Weblinks==


==Weblinks==
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926640/pdf/CEJU-71-1574.pdf Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort]
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926640/pdf/CEJU-71-1574.pdf Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort]
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924409/ Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review]
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924409/ Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review]
Line 23: Line 22:


{{refs}}
{{refs}}
[[Category:Anticonvulsants]]

Revision as of 14:53, 13 October 2018